Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to evaluate 5 different smartphone administered sun protection interventions that aim to reduce unprotected sun exposure in melanoma survivors. Participants are asked to wear an ultraviolet (UV) device and an activity monitor (Actigraph) to measure their daily UV exposure and track their physical activity for three separate assessment weeks and complete daily surveys. After the first assessment week, eligible participants are assigned up to 5 different sun protection interventions that are administered through a smartphone application for 8 weeks. Following 8-week use of the sun protection interventions, participants complete another assessment week. At the end of the assessment week, participants provide feedback on the design and usability of the UV device, smartphone application and each of the sun protection interventions that they experienced. One year later, participants are contacted again to complete a final assessment week.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potrafi mówić, czytać i pisać po angielsku
- •Miał wcześniej diagnozę melanomy, bez leczenia w ostatnich trzech miesiącach
- •Nie ma aktualnie melanomy ani nieleczonego raka skóry
- •Spędza co najmniej 15 minut dziennie na zewnątrz podczas wiosny i lata
- •Posiada smartfon z Bluetooth i WiFi
- •Chce nosić urządzenie pomiarowe przez cały dzień
- •Chce zainstalować i używać aplikację badawczą
- •Jest gotów uczestniczyć aktywnie przez do 1 roku
✗ Disqualifies
- •Ma schorzenie uniemożliwiające umiarkowaną lub intensywną aktywność fizyczną
- •Bierze udział w innym badaniu dotyczącym aktywności fizycznej
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Northwestern University
Chicago, United States
Huntsman Cancer Institute at The University of Utah
Salt Lake City, United States
Trial contact
Nabil Alshurafa, PhD
Bonnie Nolan
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.